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Chronic low-grade inflammation and reduced lymphocyte potency are implicated in the 
pathogenesis of major illnesses associated with aging. Whether this immune phenotype 
results from a loss of cell-mediated regulation or intrinsic dysregulated function of effec-
tor T cells (Teffs) requires further research. Here, we report that, as compared with young 
C57BL6 mice, old mice show an increased frequency of CD4+CD62L− Teffs with a 
dysregulated activated phenotype and markedly increased effector functions. Analysis of 
the frequency and suppressive function of CD4+FoxP3+ regulatory T cells (Tregs) indi-
cates an increase in the frequency of FoxP3+ T cells with aging which, however, occurs 
within the CD4+CD25− T cells. Furthermore, whereas Tregs from young and old mice 
similarly suppress Teffs from young mice, both have a compromised suppressive capac-
ity of Teffs from old mice, a phenomenon which is partially recovered in the presence of 
IL-2-producing CD4+CD62L+ non-Teffs. Finally, we observed that Teff subsets from old 
mice are enriched with IL-17A-producing T cells and exhibit intrinsically dysregulated 
expression of genes encoding cell-surface molecules and transcription factors, which 
play a key role in T-cell activation and regulation. We, thus, demonstrate an age-related 
impairment in the regulation of effector CD4 T cells, which may underlie the higher risk 
for destructive inflammation associated with aging.
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inTrODUcTiOn
The significant deterioration of the immune system with age, which is known as immunose-
nescence and results from lifelong chronic antigenic stress (1, 2), increases the incidence and 
susceptibility to infection and degenerative diseases at older ages (3, 4). Paradoxically, although 
immunosenescence results in immune deficiency, it is also associated with chronic low-grade 
inflammation and with a higher risk of developing age-related diseases that usually, if not always, 
Abbreviations: Teffs, effector T cells; Tregs, regulatory T cells; IFN-γ, interferon gamma; RORγ, RAR-related orphan receptor; 
TGF-βR1, transforming growth factor beta receptor 1; PD1, programmed cell death protein 1; CTLA-4, cytotoxic T-lymphocyte-
associated protein 4; ICOS, inducible T-cell costimulatory; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
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share an inflammatory pathogenesis (5, 6). The mechanism 
underlying this “Janus head” of immunosenescence is multidi-
mensional and involves both the innate and adaptive immune 
compartments (7, 8).
One of the most remarkable changes that accompany 
the process of aging is related to alterations in the function 
and maintenance of CD4+ T  cells (9–11). Although aging 
is associated with a reduced frequency of CD4+ T cells and 
with lymphopenia, it also shifts the phenotype of T cells from 
naïve to effector and memory phenotypes. In addition, human 
aging increases the frequency of activated CD4+ T  cells 
(12), which, upon stimulation, express higher levels of pro-
inflammatory cytokines [such as interferon-gamma (IFN-γ) 
(6, 13–15)]. The frequency of the highly pro-inflammatory 
Th17 T cells, which are implicated in several mouse models 
of autoimmune diseases (16–18), is also more prevalent in 
aged mice (19).
Despite intensive investigation of the frequency and compe-
tence of CD4+CD25highFoxP3+ regulatory T  cells (Tregs) in 
aged humans (20–24) and mice (25–27), findings are still con-
troversial; some studies reported no differences in the frequency 
and function of Tregs during aging (25, 26), whereas others 
show that the frequency and function of these cells are modi-
fied (20–23, 26, 27). Overall, whether the aberrant activation of 
effector T cells (Teffs) results primarily from intrinsic senescent 
properties of the cells or from a deficiency in Treg frequency 
and/or function is unclear. In this study, we, thus, analyze the 
changes Teff undergo with aging along with the frequency and 
function of Tregs.
MaTerials anD MeThODs
animals
All surgical and experimental procedures were approved by the 
Institutional Animal Care and Use committee of Ben-Gurion 
University of the Negev, Israel. C57BL/6 mice were purchased 
from The Jackson Laboratory (Bar Harbor, ME, USA) and were 
bred in our local specific pathogen-free animal facility. Mice 
were used at the age of 2–4 months (young mice) or at the age of 
18–24 months (old mice).
Flow cytometry
We used a multicolor labeling technique to detect cell-surface 
and intracellular molecules in splenocytes. Briefly, spleens 
were removed from mice and dissociated in DMEM containing 
10% fetal calf serum, 10 mM HEPES, 1 mM sodium pyruvate, 
10  mM non-essential amino acids, 1% pen/strep, and 50  μL 
β-mercaptoethanol. ACK lysis buffer was added to the solution 
for 1 min to eliminate red blood cells. Viable mononuclear cells 
were counted in a hemocytometer by using trypan blue and 
adjusted to 1 × 106 cells/mL. The following antibodies were used 
for cell-surface staining [all purchased from BioLegend (San 
Diego, CA, USA) or from Miltenyi biotec (Bergisch Gladbach, 
Germany)]: anti-CD25 (PE), anti-CD69 or anti-CCR6 (PeCy7), 
anti-CD62L (AF), and anti-CD4 or anti-CCR4 (Pacific Blue). 
To detect intracellular FoxP3, we used anti-FoxP3 (FITC or 
allophycocyanin) antibodies according to the manufacturer’s 
instructions (BioLegend). We collected data on a 10-color Gallios 
FACS machine and analyzed them with the Flowjo Pro software 
(FlowJo, LLC).
sorting
T cells were sorted using a two-step method. First, we enriched 
CD4+ T cells by using a CD4+ negative selection kit (BioLegend). 
Then, we stained CD4+ T cells with anti-CD25 (PE), anti-CD62L 
(APC), and anti-CD4 (PercP) and sorted them by FACS Aria cell 
sorter (BD biosciences, San Jose, CA, USA) to the following T-cell 
subsets: (1) non-Teffs: CD4+CD62L+ or CD4+CD62L+CD25−; 
(2) Teffs: CD4+CD62L−, CD4+CD62L−CD25−, CD4+CD62L− 
CD25−/low, or CD4+CD62L−CD25low, and (3) Tregs: 
CD4+CD25high.
stimulation assay
Sorted CD4 T-cell subpopulations were stimulated with anti-
CD3/anti-CD28 DynaBeads (Thermo Fisher scientific, MA, 
USA) for 48 h in U-shaped 96-well plates (0.5 × 105 cells/well) 
using DMEM medium containing 10% fetal calf serum, 10 mM 
HEPES, 1  mM sodium pyruvate, 10  mM non-essential amino 
acids, 1% pen/strep, and 50 μL β-mercaptoethanol. For the Tregs 
suppression assay, we cocultured sorted Teff responders with 
sorted CD4+CD25high Tregs in a 2:1 ratio. After a 48 h incuba-
tion period, we harvested the supernatants and stored them at 
−80°C until cytokine analysis.
Proliferation assay
Sorted CD62L−CD25− effector CD4 T cells were labeled with 
5 μM of carboxyfluorescein diacetate succinimidyl ester (CFSE) 
(Thermo Fisher Scientific, MA, USA) for 5 min in PBS containing 
5% fetal calf serum at room temperature. Cells were then washed 
twice, cocultured with or without CD4+CD25high Tregs in a 
2:1 ratio in U-shaped 96-well plates (0.5 ×  105  cells/well) and 
stimulated with anti-CD3/anti-CD28 DynaBeads. After a 60  h 
incubation period, CFSE dilution to daughter cells was analyzed 
with flow cytometry as previously described (28, 29).
Measurements of cytokine Production
We measured cytokine production (IL-2, IFN-γ, IL-10, and 
IL-17A) in supernatants with sandwich ELISA kits (BioLegend, 
San Diego, CA, USA), according to manufacturer’s instructions.
rna extraction and Quantitative reverse-
Transcription Pcr
We extracted total RNA from cell cultures with the miRNeasy 
Micro kit (Qiagen, Hilden, Germany) according to manufactur-
er’s instructions. We determined RNA concentrations by spectral 
absorbance at 260 nm and stored the specimens at −80°C. RNA 
(500  ng) was reverse transcribed with a high-capacity cDNA 
reverse transcription kit (Applied Biosystems, Carlsbad, CA, 
USA). Taq-Man Real-time PCR (Applied Biosystems and Roche, 
Basel, Switzerland) was used to quantify mRNA levels of RAR-
related orphan receptor (RORγ), Tbet, GATA3, transforming 
growth factor beta receptor 1 (TGF-βR1), programmed cell death 
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protein 1 (PD1), IL-10R, cytotoxic T-lymphocyte-associated pro-
tein 4 (CTLA-4), CD28, inducible T-cell costimulatory (ICOS), 
and FAS. All samples were assayed in triplicate. We used the glyc-
eraldehyde 3-phosphate dehydrogenase gene as an endogenous 
control to normalize gene expression.
statistical analyses
All statistical analyses were performed with GraphPad Prism, 
version 5.02, for windows (GraphPad software, San Diego, CA, 
USA). Data are presented as means ± SEM. p values were calcu-
lated with Student’s t-test or with two-way ANOVA.
resUlTs
aging involves a shift from non-effector 
to effector cD4+ T-cell subsets
To identify defects in cell-mediated immune regulation during 
aging, we divided CD4+ T cells into Teff and non-Teff subsets 
by using the L-selectin surface adhesion molecule CD62L, as 
described elsewhere (30). This analysis revealed a significant 
overall reduction in the frequency of CD4 T cells in old mice, 
as compared with young ones (Figures  1A,B), accompanied 
by a significant shift from a CD4+CD62L+ non-Teff subset to 
a CD4+CD62L– Teff subset in old mice (Figures  1C,D). The 
frequency of activated CD4+CD69+ T  cells in both Teff and 
non-Teffs was increased in old mice, as compared with young 
ones (non-Teffs: 12.9 ± 1.64%, as compared with 5.28 ± 0.77%, 
respectively, p <  0.001; Teffs: 36 ±  2.72%, as compared with 
22.5 ±  1.92%, respectively, p <  0.001; Figures  1E,F). In both 
young and old mice, the frequency of CD4+CD69+ T cells was 
significantly higher in the Teff subset than in the non-Teff subset 
(Figures 1E,F). To determine the functionality of Teff and non-
Teff CD4+ T  cells, we sorted CD4+CD62L+ non-Teff subsets 
and CD4+CD62L− Teff subsets obtained from young and old 
C57BL6 mice (Figure 1G) and then stimulated them with beads, 
as described in Section “Materials and Methods.” Stimulated 
CD4+ T  cells obtained from old mice secreted significantly 
higher levels of the effector cytokines IFN-γ, IL-17A, and IL-10, 
as compared with the stimulated CD4+ T cells obtained from 
young mice (Figure 1H). In CD4+ T cells obtained from either 
young or old mice, stimulating the purified non-Teff and Teff 
subsets revealed that the Teff subset secreted lower levels of 
IL-2 and higher levels of the effector cytokines IFN-γ and IL-10, 
whereas the activated non-Teff CD4+ T cells secreted primarily 
IL-2 and very small amounts of effector cytokines (Figures 1I,J). 
In addition, the levels of secreted IFN-γ and IL-10 were signifi-
cantly higher in the Teff subset of old mice than in the Teff of 
young ones (Figure  1I). An assessment of the expression of 
chemokine receptors revealed a predominant expression of the 
Th1 chemokine receptor CXCR3 in both young and old mice 
(Figures 1K–N). Within both the Teff and the non-Teff subsets, 
CD4+ T cells obtained from old mice exhibited an increased fre-
quency of CXCR3+, CCR6+, and CCR4+ T cells, as compared 
with those obtained from young mice (Figures 1K–N and Figure 
S1 in Supplementary Material). Taken together, these data dem-
onstrate that aging is accompanied by an increased incidence of 
activated Teffs and by a marked increase in cytokine release upon 
activation.
The Frequency of FoxP3+ T cells is 
increased among cD4+cD25− T cells in 
Old Mice
To determine whether the aberrant activation of T cells obtained 
from old mice results from a deficient cell-mediated regulation, we 
pursued to analyze the frequency and function of Tregs in young 
and old mice. We initially assessed the frequencies of CD25low 
and CD25high subsets among CD4+ T  cells obtained from 
young and old mice. FACS analysis revealed that CD4+ T cells 
are enriched with CD25low T cells in old mice, as compared with 
young mice (12.4 ± 0.7 and 7.5 ± 0.7%, respectively, p < 0.001; 
Figures 2A,B), and that this subset of cells is more abundant in 
the Teff (CD62L−) than in the non-Teff (CD62L+) compart-
ment in both young and old mice (Figures 2A,B). In addition, 
whereas the frequency of CD4+CD25high T cells was higher in 
Teffs than in non-Teffs in young mice (5.8 ± 0.5 and 2.7 ± 0.2%, 
respectively, p < 0.001), it was comparable in both types of cells 
in old mice (Figures 2A,C). Accordingly, the Teff subset showed 
a significantly lower frequency of CD4+CD25high T cells in old 
mice, as compared with young mice (5.8 ± 0.5 and 4.0 ± 0.4%, 
respectively, p < 0.001; Figures 2A,C). The CD25low/CD25high 
ratio was thus significantly higher in old mice than in young mice, 
predominantly among Teffs (Figure 2D).
As a more accurate measurement of Treg frequency, we 
performed an intracellular staining of splenocytes with an 
anti-FoxP3. FACS analysis revealed that the frequency of 
CD4+FoxP3+ T cells was significantly higher in old mice than in 
young mice (15.4 ± 3.09 and 8.79 ± 1.24%, respectively, p < 0.05; 
Figures 2E,F). However, this increase in FoxP3+ T cells was evi-
dent only among the CD4+CD25− T-cell subsets (9.1 ± 1.35 and 
4.4 ± 0.8%, respectively, p < 0.001; Figures 2G,H) and not among 
the CD4+CD25+ subsets. Overall, these data demonstrate that 
although the frequency of FoxP3+ T cells is increased in old mice, 
the frequencies of FoxP3+CD25+ and FoxP3+CD25high are 
similar in young and old mice. As previously shown (26, 31), the 
CD4+FoxP3+CD25− T cells that increase with aging may not 
exhibit the suppressive characteristics of CD4+FoxP3+CD25high 
T cells.
Teffs of Old Mice are Partially resistant to 
Treg-Mediated immunosuppression
Although the results in Figure 2 show no significant difference 
in the frequency of CD4+CD25high Tregs between young and 
old mice, they do show that aging causes a significant increase 
of effector CD4+CD25low T cells along with an increase in the 
CD25low/CD25high ratio. We, thus, pursued to determine the 
suppression capacity of sorted CD4+CD25high Tregs from 
young and old mice on both sorted CD4+CD62L−CD25− and 
CD4+CD62L−CD25−/low Teffs (Figure 3A). CD4+CD25high 
Tregs were first cultured with CD25− or with CD25−/low 
Teffs, in a 1:2 ratio and stimulated with anti-CD3/anti-CD28 
DynaBeads. The secretion of IL-2 from Teffs of either young or 
old mice was suppressed to a similar extent by CD4+CD25high 
FigUre 1 | aging shifts the balance from non-effector into effector cD4+ T-cell subsets with enhanced effector functions. Splenocytes were gated for 
lymphocytes (a) and then analyzed for the frequency of CD4+ T cells (B). (c–F) CD4+ T cells were gated for CD4+CD62L− effector T cell (Teff) or for 
CD4+CD62L+ non-Teff subsets, and then the frequency of CD4+CD69+ T cells was analyzed. (g–J) Splenocytes were enriched for CD4+ T cells by magnetic 
separation, stained for CD4 and CD62L, sorted into CD4+CD62L+ and CD4+CD62L− T-cell subsets (g), and stimulated with DynaBeads for 48 h. Then, cytokine 
secretion levels in the different CD4+ T-cell subsets were measured. (K–n) CD4+ T cells were gated for CD4+CD62L− Teff or for CD4+CD62L+ non-Teff subsets, 
and then the frequency of CXCR3, CCR6, and CCR4 chemokine receptors in the different subsets was analyzed. Data are shown as means ± SEM of 30 mice per 
group, pooled from five independent experiments. p values were calculated by Student’s t-test; *p < 0.05; **p < 0.01; ***p < 0.001.
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FigUre 2 | continued
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Tregs of young or old mice (Figure  3B). In addition, Tregs 
from either young or old mice suppressed the secretion of 
IFN-γ by Teffs; however, this immunosuppressive effect was 
significantly stronger on Teffs of young mice than on Teffs of 
old ones (Figure 3C). The levels of secreted IL-10 and IL-17A 
were not suppressed by Tregs obtained from young or old mice 
FigUre 2 | continued 
aging shifts the balance between activated and regulatory T cells (Tregs). To analyze the frequency of Tregs in young and old mice, splenocytes were 
harvested, stained for CD4, CD62L, CD25, CD127, and FoxP3, and subsequently analyzed by flow cytometry. (a–D) CD4+ T cells were gated for CD4+CD62L+ or 
CD4+CD62L− T cells (a). Then, the frequency of CD4+CD25low (B) and CD4+CD25high (c) T cells was analyzed, and the activated/regulatory T-cell ratio among 
CD4+ T-cell subsets was calculated (D). (e,F) CD4+ T cells were analyzed for the frequency of FoxP3+ T cells. (g,h) CD4+ T cells were analyzed for the frequency 
of FoxP3+CD25−, CD4+FoxP3+CD25+, and CD4+FoxP3+CD25high T cells. Data are shown as means ± SEM of 30 mice per group, pooled from three 
independent experiments. p values were calculated by Student’s t-test; *p < 0.05; **p < 0.01; ***p < 0.001.
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(Figures 3D,E). Comparing the activity of Tregs (isolated from 
both young and old mice) on CD25– to their activity on CD25–/
low Teffs revealed that, in cells derived from old mice, the CD25–/
low Teff subset was more resistant than the CD25– subset to 
Treg-mediated suppression of IL-2 and IFN-γ (Figures 3F,G). 
In contrast, no differences were observed in Treg-mediated 
suppression of IL-17A and IL-10 among CD25− subset, as 
compared with the CD25−/low subset, in either young or old 
mice (Figures 3H,I).
To determine whether the reduced suppressive function 
of Tregs on Teffs from old mice results from enhanced pro-
liferation of the Teffs or their enhanced cytokine production, 
we labeled sorted Teffs from young and old mice with CFSE 
and then cocultured them with Tregs from young or old 
mice, respectively. Figures 3J–M demonstrate that stimulated 
CD62L–CD25– Teffs from young mice underwent a similar 
number of proliferation cycles (Figures  3J,L) along with a 
similar reduction in CFSE MFI (Figure  3K) in the absence 
or in the presence of Tregs, whereas stimulation of this Teff 
subset from old mice yielded neither significant proliferation 
(Figures 3J,M) nor reduction in CFSE MFI (Figure 3K). These 
results suggest that Treg-mediated suppression of this particular 
Teff subset (CD4+CD25−CD62L−) is at the cytokine level and 
that this Teff subset from old mice not only exhibits dysregu-
lated cytokine production but also fails to proliferate properly 
following stimulation.
Since we examined the activity of Tregs in the absence of 
the CD4+CD62L+ subset, which is the major source of IL-2 
within CD4+CD25− T cells (Figure 1J), we next examined their 
role in the Treg suppression assay (32). To this end, we sorted 
CD62L−CD25− Teffs (Figure  4Aa) and cocultured them with 
sorted CD4+CD25high Tregs in the presence or absence of 
CD4+CD25−CD62L+ non-Teff T cells (Figure 4Ab). The T cells 
were stimulated with anti-CD3/anti-CD28 DynaBeads for 48 h, 
and IFN-γ, IL-17A, and IL–10 cytokine secretion was measured 
with ELISA. The CD4+CD62L+ T cells significantly enhanced, 
in a dose-dependent manner, the suppression function of Tregs 
derived from either young or old mice (Figures 4B–G). Notably, 
however, CD4+CD62L–CD25– Teffs cells derived from old mice, 
as compared with those derived from young ones, secreted higher 
amounts of IFN-γ, IL-17A, and IL-10 (Figures 4B,D,F) and were 
less sensitive to the regulatory impact of CD4+CD62L+ T cells 
(Figures 4C,E,G).
Teffs from Old Mice exhibit intrinsic 
Dysregulated Properties
Although the CD62L+ subset partially abrogated the resistance 
of Teffs from old mice to Treg suppression, the release of effector 
cytokines following activation remained substantially high. This 
finding indicates that Teffs from old mice exhibit intrinsic proper-
ties that attenuate the function of Tregs, and that this phenom-
enon is more pronounced in the CD25low Teff subset than in the 
CD25− Teff subset. We thus sorted both CD4+CD62L−CD25– 
and CD4+CD62L−CD25−/low Teff subsets and compared their 
cytokine profile following anti-CD3/anti-CD28 DynaBeads 
stimulation for 48 h. As compared with young mice, CD25− and 
CD25−/low Teffs derived from old mice tended to secrete lower 
levels of IL-2 (Figure 5A), but they secreted significantly higher 
levels of IFN-γ and IL-10 (Figures  5B,C). Furthermore, the 
secreted levels of IL-17 in the CD25– Teff subset were similar 
in cultures derived from both old and young mice, whereas 
they were markedly higher in CD25–/low Teff cultures derived 
from old mice (Figure  5D). Based on these data, we sorted 
the CD4+CD25low Teffs (excluding the CD25− subset) from 
young and old mice and analyze them by qRT-PCR. As shown 
in Figure  5E and Table S1 in Supplementary Material, mRNA 
levels of receptors that convey either stimulatory (e.g., CD28 and 
ICOS) or inhibitory/apoptotic (e.g., CTLA-4, TGF-βR1, IL-10R, 
PD1, and FAS) signals were higher in CD25low Teffs derived 
from old mice. Along with these data, the mRNA levels of the key 
FigUre 3 | continued
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polarizing transcription factors Tbet, RORγ, and GATA3 were 
significantly higher in CD25low Teffs from old mice (Figure 5E; 
Table S1 in Supplementary Material). Notably, IL-21, which is 
part of the differentiation and function of Th17  cells (17), was 
about seven-fold higher in this subset (Figure  5E; Table S1 in 
Supplementary Material).
FigUre 3 | continued 
effector T cell (Teff) subsets from old mice are less susceptible to the immunosuppressive activity of regulatory T cells (Tregs). (a) Splenocytes were 
harvested from young and old mice, enriched for CD4+ T cells by magnetic separation, stained for CD4, CD62L, and CD25, and subsequently sorted into 
CD4+CD62L−CD25− (aa) and CD4+CD62L−CD25−/low (ab) Teff subsets or CD4+CD25high Tregs (ac). (B–e) CD4+CD25high Tregs from young or old mice 
were cocultured for 48 h with the CD4+CD62L−CD25− and with the CD4+CD62L−CD25−/low cell subsets at a 1:2 ratio, and then cytokine production was 
measured in the supernatants by ELISA. (F–i) CD4+CD25high Tregs from young and old mice were cocultured for 48 h with CD4+CD62L−CD25− or with 
CD4+CD62L−CD25−/low cell subsets at a 1:2 ratio, and then cytokine production was measured in the supernatants by ELISA. Data are shown as percentage of 
cytokine secretion in the presence of CD4+CD25high T cells [means ± SEM of 20 mice per group, pooled from four independent experiments (each with five mice 
per group)]. p values were calculated by Student’s t-test; *p < 0.05, †p < 0.05. (J–M) Sorted carboxyfluorescein diacetate succinimidyl ester – (CFSE neg) 
CD4+CD25high Tregs from young or old mice were cocultured with CFSE-labeled CD4+CD62L−CD25− Teffs from young or old mice, respectively, in a 1:2 ratio. 
(J) Representative CFSE plots of young and old Teffs before and after stimulation (60 h). Teff proliferation was assessed by a fold decrease of CFSE MFI (K) and 
percent CFSE in each proliferation cycle as compared to non-activated (Non-act.) Teffs. Data are shown as means ± SEM of four biological repeats (each with 3–5 
mice per group). p values were calculated by two-way ANOVA; **p < 0.01, ***p < 0.001, ***p < 0.0001.
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DiscUssiOn
The goal of this study was to elucidate mechanisms contribut-
ing to age-related chronic low-grade inflammation. Our results 
demonstrate that aging is accompanied by quantitative and 
qualitative impairments in effector CD4+ T  cells. The Teff 
subsets from old mice exhibit an activated phenotype and are 
resistant to Treg-mediated immunosuppression—a defect that 
can be partially restored by IL-2-secreting non-Teffs. Finally, the 
Teff subsets from old mice are enriched with IL-17A-producing 
T cells and demonstrate intrinsically dysregulated expression of 
genes encoding cell-surface molecules and transcription factors 
which play a key role in T-cell activation and regulation. Our 
study thus suggests that aging accompanies a primary defect 
in CD62L– effector CD4 T  cells which may prone to declined 
immunity and chronic inflammation.
An increased effector:naïve T-cells ratio was previously 
observed in older mice (33, 34) and humans (35, 36), but the 
molecular properties of the distinct Teff subsets that contribute 
to compromised immunity and chronic inflammation in old age 
are still unknown. By sorting the Teff and non-Teff CD4 subsets, 
we show that, effector cytokines are expressed primarily by 
CD62L− Teffs, whereas primarily IL-2 is expressed by the non-
Teff CD62L+ cells. Such a distinction between the CD62L– and 
CD62L+ subsets allows an accurate analysis of the effector and 
regulatory properties of lymph node and inflammatory site-
homing CD4 T  cells. Focusing on the Teff subsets to elucidate 
the mechanisms underlying chronic inflammation in old age 
reveals that aging is accompanied by an increased frequency of 
readily activated CD4 Teffs. Following stimulation, Teffs from 
old mice secrete considerably higher levels of effector cytokines 
than Teffs from young mice, as was previously described in patho-
logical conditions associated with chronic inflammation, e.g., in 
patients with Guillain–Barre syndrome, neuropathic diseases 
(37), and rheumatoid arthritis (38). Since the non-Teff subsets 
almost completely lack effector functions [(30, 33), Figure 1], the 
increased level of cytokine secretion from CD4+ T cells derived 
from old mice is most likely the result of a combination between 
an increased frequency of Teff subsets and an aberrant regulation 
of their function.
We then investigated whether cell-mediated regulatory 
mechanisms are impaired in old mice. We show that aging is 
accompanied by an imbalance between CD4+CD25low and 
CD4+CD25high T cells, predominantly among Teffs. This find-
ing supports previous studies, which demonstrated that aging 
is associated with a shift from Tregs to Teff subsets (39). Also 
in line with previous studies, we show that the frequency of 
FoxP3+ T cells is increased in old mice (26, 40–43). However, 
this increase occurred within the CD4+CD25– and not within 
the CD4+CD25high subset. Previous studies have shown that 
mice lacking CD25 or the IL-2 cytokine demonstrate a similar 
increase in the number of immature CD4+CD25–FoxP3low 
Tregs (44–46) and have reduced capability to suppress autoreac-
tive T cells in vivo (44, 47). Furthermore, CD4+CD25lowFoxP3+ 
T cells were recently implicated in the pathogenesis of RA as cells 
which can lose FoxP3 expression and accumulate at the inflamed 
joints as Th17 T cells (48). Taken together, our results demon-
strate that, although the frequency of CD4+FoxP3+ T  cells 
generally increased with aging, it occurred in our study within 
the CD4+CD25– subset which exhibited substantially increased 
effector functions as compared to this subset from young mice 
(Figure 5). Additional studies are though required to elucidate 
aging-related alterations in the frequency and functionality of 
CD4+FoxP3+CD25low/– T cells.
Beside the frequency, the functionality of Tregs is a cru-
cial factor that contributes to immune tolerance (49, 50). 
CD4+CD25high Tregs from either young or old mice demon-
strated, overall, similar suppressive functions when they were 
cocultured with CD4+CD62L−CD25− Teffs. This finding is 
in line with previous studies, which indicated that Tregs from 
young and old mice similarly suppress CD4 T-cell prolif-
eration (23, 26, 41), IFN-γ production (40), and T cell-driven 
autoimmune colitis (25). An important aspect of our study 
relates to the capacity of Tregs to suppress old mice-derived 
Teffs: the CD4+CD62L−CD25−, and to a further extent, the 
CD4+CD62L−CD25−/low Teffs were resistant to Treg suppres-
sion as compared with the same T-cell subsets from young mice. 
Notably, Tregs did not affect the proliferation of these effector 
subsets but rather they suppressed the production of effector 
cytokines. Thus, given the marked higher levels of cytokines 
produced by Teffs from old mice, in particular, the IL-17A and 
IL-21 cytokines of the Th17 lineage, it is likely that the Treg 
resistance among Teff subsets from old mice is at the level of 
dysregulated cytokine production. Suppression of Teffs in our 
study was though substantially enhanced when, in addition 
to the Teff responder cells, the culture also included non-Teffs 
FigUre 4 | continued
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FigUre 4 | continued 
cD4+cD62l+ non-effector T cell (Teff) subsets improve the immunosuppressive effects of cD4+cD25high Tregs in an age-dependent manner.  
(a) Splenocytes were harvested from young and old mice, enriched for CD4+ T cells by magnetic separation, stained for CD4, CD62L, and CD25, and 
subsequently sorted into a CD4+CD62L−CD25− Teff subset (aa), a CD4+CD62L+CD25– non-Teff subset (ab) or CD4+CD25high Treg cells as shown in 
Figure 3a. The sorted CD4+CD62L−CD25− Teff subsets were cocultured for 48 h with CD4+CD25high Treg cells at a2:1 ratio, with or without sorted 
CD4+CD62L+CD25− non-Teff subsets, and then cytokine production was measured in the supernatant by ELISA. (B,D,F) Cytokine secretion levels. (c,e,g) 
Percent cytokine secretion in the presence of CD4+CD62L+CD25− non-Teffs. Data are shown as means ± SEM of eight mice per group, pooled from two 
independent experiments (each with four mice per group). p values were calculated by Student’s t-test; *p < 0.05.
FigUre 5 | continued
FigUre 5 | continued 
The pattern of cytokine and gene expression is dysregulated in 
effector T cells (Teffs) from old mice. (a–D) Splenocytes were harvested 
from young and old mice, enriched for CD4+ T cells by magnetic separation, 
stained for CD4, CD62L, and CD25, and subsequently sorted into 
CD4+CD62L–CD25– and CD4+CD62L–CD25–/low Teff subsets as shown in 
Figure 3a. The sorted Teff subsets were stimulated for 48 h and then 
cytokine production was measured in the supernatant by ELISA. Data are 
shown as means ± SEM of four or nine independent experiments (each with 
4–5 mice per group) with CD4+CD62L–CD25–/low or CD4+CD62L–CD25– 
Teff subsets, respectively. (e) CD4+CD62L–CD25low Teff subsets were 
sorted from young and old mice and total RNA was extracted. The RNA was 
reverse transcribed with a high-capacity cDNA reverse-transcription kit, and 
gene expression was analyzed with qPCR and is shown as fold change in old 
mice relative to young mice. Data are shown as means ± SD of 3–4 mice per 
group, representing three independent experiments (each with 3–4 mice per 
group). p values were calculated by Student’s t-test; *p < 0.05; **p < 0.01; 
***p < 0.001. The calculated means, SDs, and p values are provided in Table 
S1 in Supplementary Material.
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(which are a major source for IL-2), a phenomenon that was more 
pronounced in T-cell cultures derived from young mice than 
those derived from old mice. The implications of these findings 
are two-fold: first, rather than using the entire CD4+CD25− 
T  cells (including effector and non-Teffs) as responder cells, 
the use of sorted resting (CD4+CD62L−CD25−) and activated 
(CD4+CD62L−CD25+) Teff subsets with or without the 
CD4+CD62L+CD25− non-Teffs, may provide a more accurate 
measure of the actual regulatory capacity of Tregs at inflamma-
tory sites in vivo; second, while Tregs from old mice maintain 
their functional properties, they may fail to control chronic 
inflammation due to, at least in part, insufficient levels of IL-2 
(32, 51–54). Further studies are required to determine the role 
of CD4+CD62L+ T cells in enhancing the suppression of Teffs 
both in vitro and in vivo along with the contribution of aging to 
this phenomenon.
Despite the comparable suppressive functions of Tregs from 
young and old mice, we found that Teffs from old mice are 
more resistant than Teffs from young mice to the immunosup-
pressive effects of Tregs. Such resistance to suppression was 
previously reported in several animal models of autoimmune 
diseases—including models of diabetes (55), experimental 
autoimmune encephalomyelitis (56), and systemic lupus erythe-
matosus (57) and in humans with systemic lupus erythematosus 
(58, 59). Moreover, it has been shown that CD4+CD28null T cells, 
which accumulate during aging and are highly enriched with 
activated Teffs, are less prone to regulation by CD4+CD25high 
T cells, as compared with CD4+CD28+ T cells (60). In our study, 
this resistance was more pronounced when, in addition to the 
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CD4+CD62L–CD25– T cells, the responder cells also included the 
CD25low Teff subset. An ex vivo assessment of the functionality 
and molecular signature of the CD4+CD25low Teff subset from 
old mice revealed that, as compared with young mice, this subset 
exhibits increased effector functions along with upregulation of 
the key polarizing transcription factors Tbet, RORγ, and GATA3 
as well as upregulation of cell-surface molecules which tightly 
regulate T-cell activation. Taken together, our data suggest that 
aging results in accumulation of aberrantly regulated CD4 T cells 
which on one hand exhibit increased activation threshold (i.e., 
increased levels of CTLA-4 and PD1) and thus reduced potency 
and on the other hand dysregulated effector functions, which can 
cause chronic inflammation (7, 19, 40, 61, 62). A more extensive 
analysis is required to explore the changes Teff subsets undergo 
during aging along with identifying key regulators of this process 
possibly serving as therapeutic targets for intervention in T cell 
senescence.
In summary, the findings reported in this study highlight 
fundamental aging-related alterations of Teffs, which impair the 
balance between protective and pathogenic immune responses, 
and may explain the development of age-related chronic inflam-
mation and/or a compromised immunity to pathogens, tumors, 
and tissue repair. Translated clinically, the ability of Treg cells to 
downregulate autoinflammation suggests that improving Treg 
functionality in old subjects via the administration of IL-2 or 
IL-2-producing T  cells may have therapeutic implications for 
dampening the risk for senescence-associated inflammation 
without compromising immunity. Such a strategy may show bet-
ter efficacy when, in parallel to IL-2 therapy, drugs targeting the 
intrinsic dysregulated properties of Teffs are explored.
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